Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aminopyridines/therapeutic use"'
Autor:
Simon Fage, Claus Johansen
Publikováno v:
Fage, S & Johansen, C 2023, ' Severe and therapeutic challenging oral erosive lichen planus treated with oral roflumilast ', Clinical and Experimental Dermatology, vol. 48, no. 5 . https://doi.org/10.1093/ced/llad041
Convincing and rapid effect of oral roflumilast in a patient with otherwise treatment-resistant severe oral erosive lichen planus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::254dc4eb9a4ab4852a87cb191fe6592a
https://doi.org/10.1093/ced/llad041
https://doi.org/10.1093/ced/llad041
Autor:
Daniel Peckham, Paul Whitaker, Anil Mehta, Sinisa Savic, Michael F. McDermott, T. Scambler, J. Holbrook, Christine Etherington, Ian Clifton, Heledd H. Jarosz-Griffiths, Samuel Lara-Reyna, Giulia Spoletini, C. Wong, Fabio Martinon
Publikováno v:
eLife
eLife, Vol 9 (2020)
eLife, vol. 9, pp. e54556
eLife, Vol 9 (2020)
eLife, vol. 9, pp. e54556
Previously, we showed that serum and monocytes from patients with CF exhibit an enhanced NLRP3-inflammasome signature with increased IL-18, IL-1β, caspase-1 activity and ASC speck release (Scambler et al. eLife 2019). Here we show that CFTR modulato
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e56c3b19820b0ec649de1acb486b5ee6
https://eprints.whiterose.ac.uk/158253/7/elife-54556-v2.pdf
https://eprints.whiterose.ac.uk/158253/7/elife-54556-v2.pdf
Publikováno v:
Revue médicale suisse, Vol. 13, No 544-545 (2017) pp. 96-101
We chose, for this update on novelties in treatments for pulmonary disorders in 2016, to focus on advances in 3 pulmonary disorders : chronic obstructive pulmonary disease (COPD), asthma and IPF. For COPD, the contribution of inhaled glucocorticoster
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1400::367fdfc0edf707ab11bb935747c85963
https://archive-ouverte.unige.ch/unige:111203
https://archive-ouverte.unige.ch/unige:111203